Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS).

Titel:: Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS).
Dokumenttyp:: Journal Article; Letter
Autor(en):: Mossner, M; Jann, J-C; Nowak, D; Platzbecker, U; Giagounidis, A; Götze, K; Letsch, A; Haase, D; Shirneshan, K; Braulke, F; Schlenk, R F; Haferlach, T; Schafhausen, P; Bug, G; Lübbert, M; Ganser, A; Büsche, G; Schuler, E; Nowak, V; Pressler, J; Obländer, J; Fey, S; Müller, N; Lauinger-Lörsch, E; Metzgeroth, G; Weis, C; Hofmann, W-K; Germing, U; Nolte, F
Zeitschriftentitel:: Leukemia
Jahr:: 2016
Band / Volume:: 30
Heft / Issue:: 9
Seitenangaben Beitrag:: 1956-9
Sprache:: eng
Volltext / DOI:: doi:10.1038/leu.2016.111
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/27133825
Print-ISSN:: 0887-6924
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: